article thumbnail

Biologics Development in Immunology and Inflammation — Featuring Amir Reichman, CEO of Scinai Immunotherapeutics – Xtalks Life Science Podcast Ep. 147

XTalks

This episode features an interview with Amir Reichman, CEO of Scinai Immunotherapeutics , a biopharma company focused on developing cutting-edge biological treatments within the inflammation and immunology (I&I) sector, with a primary focus on addressing autoimmune and infectious diseases.

article thumbnail

Build Connections with B2B Audiences through the Xtalks Life Science Podcast

XTalks

Life science podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the life science industry. The result?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Developing More Affordable Cellular Immunotherapies: Interview with CytoMed Therapeutics — Xtalks Life Science Podcast Ep. 117

XTalks

Established in 2018, CytoMed is a biotechnology firm that originated from the Agency for Science, Technology and Research (A*STAR), Singapore’s premier public sector research and development agency. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

article thumbnail

Life Science Trends to Look Out for in 2024

XTalks

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.

article thumbnail

Revolutionizing Orthopedic Joint Replacement — Interview with Ben Sexson, Co-Founder, CEO, Monogram Orthopedics – Xtalks Life Science Podcast Ep. 142

XTalks

Monogram is focused on developing patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. Ben is an engineer by training and before joining Monogram, he served as the Director of Business Development at Pro-Dex, an OEM manufacturer of Orthopedic Robotic End-Effectors.

article thumbnail

Developing Conditionally Active Antibodies Targeting the Tumor Microenvironment ft. John K. Celebi, CEO, Sensei Bio – Xtalks Life Science Podcast Ep. 156

XTalks

Celebi, MBA, President & Chief Executive Officer, Sensei Biotherapeutics , a clinical-stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

article thumbnail

Gene Editing Innovations with Programmable Gene Insertion (PGI) Technology ft. John Finn, PhD, CSO, Tome Biosciences – Xtalks Life Science Podcast Ep. 160

XTalks

In this episode, Ayesha spoke with John Finn, PhD, Chief Scientific Officer at Tome Biosciences , a company developing programmable gene insertion (PGI) technology. PGI is a revolutionary approach for the development of potentially curative cell and integrative gene therapies.